MAP2K7 and polycystic ovary syndrome: Indeed, as illustrated in Figure 3, most of the factors that were identified as playing a role in the hyperandrogenism of women with PCOS, such as lipotoxicity, reduced MEK/ERK activity, and insulin resistance, could potentially be corrected by AT2R-specific activation.